Supplement analysis backed by scientific evidence · PT

← All supplements
Limited evidenceBrain & cognition

Nootropic Blends

A handful of nootropic ingredients have modest individual evidence (caffeine plus L-theanine, citicoline, bacopa), but multi-ingredient "brain" blends are rarely tested as sold, usually under-dose the components, and a worrying share of the category has been found spiked with unapproved drugs.

What the science says

  • The blends themselves are almost never tested Limited evidence

    Commercial nootropic stacks combine 8-15 ingredients, of which only a few (caffeine, L-theanine, citicoline, bacopa, alpha-GPC) have any human cognitive data. Independent trials of finished products are rare, short (often single-dose), and typically manufacturer-funded, with outcomes on reaction-time batteries whose real-world relevance is unclear.

  • Caffeine + L-theanine is the one combination with reasonable support Moderate evidence

    Roughly 50-100 mg caffeine with 100-200 mg L-theanine improves attention-switching accuracy and reduces distractibility in acute crossover trials, with theanine blunting caffeine-related jitteriness. Effects are real but small and short-lived, and much of the benefit is simply caffeine.

  • Effects in healthy young adults are much smaller than in deficient or impaired groups Limited evidence

    Bacopa (300 mg/day standardised extract) shows memory-acquisition benefits mainly after 8-12 weeks and largely in older adults; ginkgo, huperzine A and citicoline show their clearest signals in mild cognitive impairment or in people with poor baseline status, not in healthy high performers. The category markets impairment-population data to unimpaired customers.

  • Unapproved drugs are commonly found in this category Strong evidence

    Analytical testing of cognitive-enhancement supplements has identified unapproved pharmaceuticals — omberacetam (noopept), aniracetam, phenibut, vinpocetine and picamilon — sometimes at doses several times a typical pharmaceutical dose, and often with the actual content differing sharply from the label. A broader review documents that these unauthorised nootropic ingredients are widespread internationally and several are relevant as doping agents.

Dosage & safety

Studied doseIngredient doses with support: caffeine 50-200 mg with L-theanine 100-200 mg (acute); citicoline 250-500 mg/day; bacopa 300 mg/day of a standardised extract (50% bacosides) for 8-12 weeks; alpha-GPC 400-1,200 mg/day; Rhodiola 200-600 mg/day for fatigue. Typical blend labels: bacopa 100-150 mg, alpha-GPC 100-200 mg, lion's mane 250-500 mg fruiting-body-equivalent (often mycelium-on-grain), plus a proprietary blend that hides amounts — usually one-third to one-half of studied doses.
SafetyCommon issues are stimulant-related (insomnia, anxiety, elevated heart rate) and GI upset from bacopa. Huperzine A is a cholinesterase inhibitor and should not be combined with cholinergic drugs or used continuously. Vinpocetine is banned from supplements in several jurisdictions and the FDA has warned it may cause miscarriage or fetal harm; it is prescription-only in parts of Europe. Phenibut carries genuine dependence and withdrawal risk, with reported cases of severe withdrawal syndromes, and racetams are unapproved drugs in the US and prescription medicines elsewhere. Because label accuracy in this category is poor, athletes subject to testing and anyone on psychiatric medication should be especially cautious.

Scientific references

Where to buy

Troomy Nootropics, Brain Power, 60 Capsules

View on iHerb

Referral link — this site may earn a commission on purchases.

Related in Brain & cognition